Beijing Weifeng Yimin Bio-Technology Limited Company
发明人:
申请号：
EP12870905.2
公开号：
EP2823818A1
申请日:
2012.05.18
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
Disclosed is the use of rupatadine in the manufacture of pharmaceutical composition for preventing or treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease. The new medicament, i.e. rupatadine, for treating chronic obstructive pulmonary disease is obvious in therapeutic effects, and low in toxic and side effects, and safe in use in the aspects of treating chronic obstructive bronchitis, obstructive emphysema or chronic obstructive pulmonary disease.
